INTEGRA LIFESCIENCES HOLDINGS CORP - 8-K Filing
Integra LifeSciences stockholders approved an increase of 3,550,000 shares under its equity incentive plan at the May 7, 2026 annual meeting. The amendment raised the total share limit to 24,250,000 and was passed with 98% in favor. All director nominees were elected, PwC was ratified as auditor (91%), and executive compensation received advisory approval (97%). (Items: 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Offi, 5.07 Submission of Matters to a Vote of Security HoldersThe Annual Meeting of the Company was held on May 7, 2026, 9.01 Financial Statements and Exhibits(d) Exhibits10)
Tickers: $IART